Bahija Jallal
Chief Executive Officer presso IMMUNOCORE HOLDINGS PLC
Patrimonio netto: 2 M $ in data 29/02/2024
Profilo
Dr. Bahija Jallal is an Independent Director at Arrivent BioPharma, Inc., a Chief Executive Officer & Director at Immunocore Holdings Plc, a Chief Executive Officer & Director at Immunocore Ltd., an Independent Director at Elevance Health, Inc. and a Council Member at National Academies of Sciences.
She is on the Board of Directors at Arrivent BioPharma, Inc., Immunocore Holdings Plc, Immunocore Ltd., Elevance Health, Inc., The Johns Hopkins University, Anthem, Inc. and Umb Health Sciences Research Park Corp.
Dr. Jallal was previously employed as an Independent Director by Guardant Health, Inc., a President by Association for Women in Science, an Executive Vice President by AstraZeneca PLC, a President by MedImmune LLC, a Vice President-Drug Assessment & Development by Chiron Corp., and a Non-Executive Director by ADC Therapeutics SA. She also served on the board at Viela Bio, Inc.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ELEVANCE HEALTH, INC.
0.00% | 10/05/2023 | 3 799 ( 0.00% ) | 2 M $ | 29/02/2024 |
IMMUNOCORE HOLDINGS PLC
-.--% | 16/02/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
ARRIVENT BIOPHARMA, INC.
-.--% | 26/01/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Bahija Jallal
Società | Posizione | Inizio |
---|---|---|
ELEVANCE HEALTH, INC. | Director/Board Member | 01/02/2018 |
IMMUNOCORE HOLDINGS PLC | Chief Executive Officer | 01/01/2019 |
ARRIVENT BIOPHARMA, INC. | Director/Board Member | 15/02/2022 |
The Johns Hopkins University | Director/Board Member | 01/01/2014 |
Umb Health Sciences Research Park Corp. | Director/Board Member | - |
National Academies of Sciences
National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services The National Academies of Sciences provides advisory services in the areas of science, technology, and health policy. | Corporate Officer/Principal | - |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Chief Executive Officer | 01/01/2019 |
Anthem, Inc. (DSG) | Director/Board Member | - |
Precedenti posizioni note di Bahija Jallal
Società | Posizione | Fine |
---|---|---|
GUARDANT HEALTH, INC. | Director/Board Member | 15/06/2022 |
░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░ ░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Bahija Jallal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
ASTRAZENECA PLC | Health Technology |
GUARDANT HEALTH, INC. | Health Services |
ELEVANCE HEALTH, INC. | Health Services |
ADC THERAPEUTICS SA | Health Technology |
IMMUNOCORE HOLDINGS PLC | Health Technology |
ARRIVENT BIOPHARMA, INC. | Health Technology |
Aziende private | 9 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Université Pierre et Marie Curie | Consumer Services |
Association for Women in Science
Association for Women in Science Miscellaneous Commercial ServicesCommercial Services The Association for Women in Science is an organization that supports and recognizes women in science, technology, engineering, and mathematics. The non-profit company is based in Washington. The organization provides a central repository for articles, blogs, press releases, webinars, videos, and newsletters, as well as curated content for women in STEM. The organization also educates about Title IX protections and how to report violations. The AWIS Wall of WISdom provides inspiration and advice from other women in science and STEM. Meredith R. Gibson has been the CEO of the American company since 2022. | Commercial Services |
National Academies of Sciences
National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services The National Academies of Sciences provides advisory services in the areas of science, technology, and health policy. | Commercial Services |
Viela Bio, Inc.
Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
Umb Health Sciences Research Park Corp. | |
Anthem, Inc. (DSG) | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |